Global Syphilis Sequencing
Whole Genome Sequencing of Syphilis Using Routine Clinical Samples
1 other identifier
observational
726
1 country
5
Brief Summary
Syphilis is an important sexually transmitted infection. There has been an epidemic of syphilis amongst men who have sex with men in the United Kingdom in the last decade. Early infection with syphilis causes a genital ulcer followed, in the absence of treatment, by a generalised illness often accompanied by rash. Studies on syphilis have been limited because it is not possible to grow syphilis outside of the body. New approaches allow the whole genetic sequence of Treponema pallidum to be obtained from a swab. In this study residual DNA collected as part of routine patient care of patients seen at sexual health clinics in the UK will be used for sequencing. No patient contact is involved in the study which is limited to whole genome sequencing using residual material from samples. By better understanding the genome of the T.pallidum insights will be gained in to the pathogenesis of this important sexually transmitted disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Typical duration for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2018
CompletedStudy Start
First participant enrolled
October 8, 2018
CompletedFirst Posted
Study publicly available on registry
October 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedApril 12, 2022
April 1, 2022
2.2 years
October 8, 2018
April 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Genomic Diversity of Treponema Pallidum as assessed by nucleotide diversity and phylogenetic lineage
Whole genome sequencing of UK and global syphilis samples combined with phylogenomic and population genomic analyses to determine the population structure and diversity of Treponema both regionally and in global context. Diversity will be assessed by measuring nucleotide diversity between samples and reference genomes.
Measured at baseline - time of enrollment. There are no further samples or visits in the study.
Study Arms (1)
Syphilis
Patients with syphilis and detectable Treponema pallidum DNA in a routinely collected clinical sample
Interventions
Residual DNA from clinical samples will be utilised for whole genome sequencing of Treponema pallidum the causative agent of syphilis
Eligibility Criteria
Patients presenting to sexual health services in UK with a diagnosis of syphilis. We will identify residual T.pallidum DNA from routinely collected clinical samples held at participating clinics/hospitals. Data accompanying these samples will be anonymised and will not include patient identifiable information. Accompanying data will include: city of origin, age, gender, HIV status and sexual orientation.
You may qualify if:
- Diagnosis of syphilis
You may not qualify if:
- No PCR positive clinical sample
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
University Hospitals Birmingham
Birmingham, United Kingdom
Brighton and Sussex NHS Trust
Brighton, United Kingdom
Leeds University Teaching Hospital
Leeds, United Kingdom
Mortimer Market Centre
London, United Kingdom
Penine Acute Hospitals Trust
Manchester, United Kingdom
Biospecimen
Residual DNA from routine clinical samples (lesion swabs/serum) of patients with Syphilis
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2018
First Posted
October 17, 2018
Study Start
October 8, 2018
Primary Completion
December 31, 2020
Study Completion
February 28, 2022
Last Updated
April 12, 2022
Record last verified: 2022-04